Sunday, July 13, 2025 9:30:47 AM
BIONANO GENOMICS has orchestrated a powerful alliance across technology, automation, software, and clinical diagnostics to bring Optical Genome Mapping (OGM) to market with precision and scale. MICROSOFT provides the cloud infrastructure that powers high-speed genomic analysis, while BioDISCOVERY’s software suite integrates OGM with other genomic platforms for seamless interpretation. DIAGENS enhances diagnostic accuracy through AI-driven analysis, especially in reproductive health, and LINEAGEN delivers clinical testing directly to patients, validating OGM’s utility in neurodevelopmental disorders. REVVITY supports reagent consistency and workflow automation, ensuring global scalability. HAMILTON and TECAN round out the ecosystem by automating sample preparation and lab workflows, making OGM plug-and-play for clinical labs. Together, these partners form a synchronized pipeline, from DNA extraction to clinical insight, that positions OGM as a disruptive yet enduring force in precision medicine.
Microsoft (MSFT) $503.32 a share
Revvity (RVTY) $101.50 a share
Bionano Genomics (BNGO) $3.40 a share
“If you want to soar like an eagle, don’t hang out with turkeys.”
Recent BNGO News
- Bionano to Report Fourth Quarter and Full Year 2025 Financial Results and Host a Conference Call Webcast on March 23, 2026 • GlobeNewswire Inc. • 03/09/2026 08:05:00 PM
- Bionano Symposium 2026 Concluded with 9 Speakers Describing the Breadth of Bionano Solutions and Their Potential for Use on a Large Scale • GlobeNewswire Inc. • 02/27/2026 01:00:00 PM
- 10 Presentations on Day 3 of Bionano Symposium 2026 Showcase OGM’s Utility in Unraveling the Complex Puzzles of Constitutional Genetic Disorders • GlobeNewswire Inc. • 02/26/2026 01:00:00 PM
- 11 Presentations on Day 2 of Bionano Symposium 2026 Showcase Expanding Impact of Optical Genome Mapping Across Oncology and Cell & Gene Therapy • GlobeNewswire Inc. • 02/25/2026 01:00:00 PM
- 9 Presentations Kick Off Day 1 of the Bionano Symposium 2026 Covering Advances in Optical Genome Mapping for Hematologic Malignancies • GlobeNewswire Inc. • 02/24/2026 01:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/18/2026 09:31:45 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/18/2026 09:29:36 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/18/2026 09:28:24 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/18/2026 09:26:55 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/18/2026 09:25:37 PM
- Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend] • Edgar (US Regulatory) • 02/17/2026 09:06:07 PM
- Bionano Announces Bionano Symposium 2026: Global Experts Showcase Advances and Innovation in Optical Genome Mapping • GlobeNewswire Inc. • 02/09/2026 02:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/04/2026 09:19:48 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/04/2026 09:18:34 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/04/2026 09:17:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/04/2026 09:16:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/04/2026 09:14:16 PM
- Bionano Announces Publication from Sanford Burnham Prebys Medical Discovery Institute Describing use of OGM to Detect Genomic Alterations Introduced by Gene Editing Technologies • GlobeNewswire Inc. • 02/04/2026 01:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/12/2026 01:15:51 PM
- Bionano Reports Preliminary Fourth Quarter and Full-Year 2025 Results • GlobeNewswire Inc. • 01/12/2026 01:00:00 PM
- Bionano Recaps Advances in Optical Genome Mapping Showcased at AMP 2025 • GlobeNewswire Inc. • 12/11/2025 01:00:00 PM
- Final 2026 Clinical Lab Fee Schedule Indicates a 47% Increase in Payment Determination for the Category I CPT Code for OGM use in Hematologic Malignancies • GlobeNewswire Inc. • 12/03/2025 01:00:00 PM
Exxe Group Advances Platform Strategy and Share Structure Reduction Following Strategic Meetings • AXXA • Mar 11, 2026 1:03 PM
DRCR Pushes Forward With Implementation of 2026 Business Plan • DRCR • Mar 11, 2026 12:26 PM
Record Gold Prices Reshape Opportunities for Emerging Producers • LFLR • Mar 11, 2026 9:00 AM
C2 Blockchain Reports 803 Million DOG (Bitcoin) Holdings Following Strategic Accumulation of Bitcoin-Native Digital Assets • CBLO • Mar 10, 2026 8:00 AM
RENI Completes Due Diligence on Target Acquisition; Confirms Strong Asset Base and Operational Performance • RENI • Mar 5, 2026 10:15 AM
BlackStar Engages in Talks with U.S. Senate Banking Committee Team Covering the Digital Asset Market Clarity Act • BEGI • Mar 4, 2026 4:47 PM
